Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "66600363161afa2274ff2ff7",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "olmesartan cilnidipine chlorthalidone| OLMISTRUM TRIO 20",
"description": "\nOlmesartan Cilnidipine Chlorthalidone is a trusted triple-combination prescription medicine widely used for the management of high blood pressure (hypertension). It combines three powerful ingredients that work together through different mechanisms to help lower blood pressure, reduce cardiovascular risk, and improve overall heart health.\n\nFor patients whose blood pressure is not controlled with single or dual therapy, doctors often recommend Olmesartan Cilnidipine Chlorthalidone as an advanced treatment option. If you are searching for this medicine online, this complete guide explains its uses, benefits, dosage, side effects, and why it may be the right choice under medical supervision.\n\nWhat is Olmesartan Cilnidipine Chlorthalidone?\n\nOlmesartan Cilnidipine Chlorthalidone is a combination tablet containing:\n\nOlmesartan – An angiotensin receptor blocker (ARB) that relaxes blood vessels.\nCilnidipine – A calcium channel blocker that widens arteries and improves circulation.\nChlorthalidone – A thiazide-like diuretic that removes excess salt and water from the body.\n\nThis triple combination helps provide stronger blood pressure control than many single-drug therapies.\n\nHow Does Olmesartan Cilnidipine Chlorthalidone Work?\n\nEach ingredient supports healthy blood pressure in a different way:\n\nOlmesartan Action\n\nOlmesartan blocks angiotensin II, a chemical that narrows blood vessels. This helps arteries relax and reduces blood pressure.\n\nCilnidipine Action\n\nCilnidipine relaxes blood vessel walls by blocking calcium entry into smooth muscles. It also helps reduce pressure load on the heart.\n\nChlorthalidone Action\n\nChlorthalidone increases urine production, helping remove extra sodium and fluid. This lowers blood volume and reduces pressure.\n\nTogether, Olmesartan Cilnidipine Chlorthalidone offers complete blood pressure management.\n\nCommon Uses of Olmesartan Cilnidipine Chlorthalidone\n\nDoctors may prescribe this medicine for:\n\n1. Hypertension\n\nUsed to treat moderate to severe high blood pressure.\n\n2. Uncontrolled BP on Dual Therapy\n\nRecommended when two medicines are not enough to achieve target readings.\n\n3. Cardiovascular Risk Reduction\n\nLowering blood pressure may reduce the risk of stroke, heart attack, and kidney damage.\n\n4. Long-Term BP Maintenance\n\nHelps maintain stable blood pressure when taken regularly.\n\nKey Benefits of Olmesartan Cilnidipine Chlorthalidone\n\nChoosing Olmesartan Cilnidipine Chlorthalidone may provide several advantages:\n\nPowerful Triple Action\n\nThree proven medicines in one tablet for stronger control.\n\nBetter Blood Pressure Stability\n\nHelps maintain steady readings throughout the day.\n\nReduced Fluid Retention\n\nChlorthalidone helps remove excess water and salt.\n\nHeart Protection\n\nMay lower strain on the heart and arteries.\n\nKidney Support\n\nProper BP control can help protect kidney function over time.\n\nConvenient Single Tablet\n\nInstead of taking multiple medicines separately, one tablet can improve convenience and adherence.\n\nWho May Need Olmesartan Cilnidipine Chlorthalidone?\n\nYour doctor may recommend olmesartan, cilnidipine, and chlorthalidone if you have:\n\nPersistent high blood pressure\nBP uncontrolled with one or two medicines\nHigh cardiovascular risk factors\nNeed for stronger combination treatment\nFluid-related BP elevation\n\nThis medicine should be used only under medical guidance.\n\nHow to Take Olmesartan Cilnidipine Chlorthalidone\n\nAlways use exactly as prescribed.\n\nGeneral Instructions:\nTake once daily or as directed\nSwallow tablet whole with water\nCan be taken with or without food\nTake at the same time every day\nDo not skip doses\n\nRegular use gives the best results.\n\nDosage Information\n\nThe correct strength depends on:\n\nBlood pressure level\nAge\nKidney function\nOther health conditions\nResponse to treatment\n\nYour doctor may adjust the dose after monitoring your readings.\n\nPossible Side Effects of Olmesartan Cilnidipine Chlorthalidone\n\nLike all medicines, side effects can occur.\n\nCommon Side Effects\nDizziness\nHeadache\nIncreased urination\nWeakness\nSwelling in ankles\nTiredness\nNausea\nSerious Side Effects\n\nSeek medical attention if you notice:\n\nSevere dizziness or fainting\nVery low blood pressure\nIrregular heartbeat\nSevere dehydration\nReduced urine output\nAllergic reaction\nChest pain\nImportant Precautions\n\nBefore taking Olmesartan Cilnidipine Chlorthalidone, inform your doctor if you have:\n\nKidney disease\nLiver disease\nDiabetes\nLow sodium or potassium levels\nGout\nHeart disease\nPregnancy or planning pregnancy\nDehydration history\n\nRoutine blood tests may be advised.\n\nDrug Interactions\n\nThis combination may interact with:\n\nOther blood pressure medicines\nPotassium supplements\nNSAID painkillers\nLithium\nSteroids\nDiabetes medicines\nDiuretics\nAlcohol\n\nAlways share all medicines and supplements with your doctor.\n\nWhy Buyers Choose Olmesartan Cilnidipine Chlorthalidone\n\nMany patients and healthcare professionals prefer Olmesartan Cilnidipine Chlorthalidone because:\n\nStrong and reliable BP control\nTriple therapy convenience\nHelps when dual therapy fails\nTrusted prescription treatment\nSupports long-term cardiovascular health\nBetter treatment compliance with one tablet\nStorage Instructions\n\nStore the tablets properly:\n\nKeep at room temperature\nProtect from moisture and sunlight\nStore in original strip or pack\nKeep away from children\n\nDo not use expired medicine.\n\nFrequently Asked Questions\nWhat is Olmesartan Cilnidipine Chlorthalidone used for?\n\nIt is mainly used to treat high blood pressure.\n\nCan I take it daily?\n\nYes, if prescribed by your doctor.\n\nDoes it increase urination?\n\nYes, chlorthalidone may increase urine output.\n\nCan this medicine cure hypertension?\n\nIt controls blood pressure but usually does not cure the condition.\n\nHow long should I take it?\n\nDuration depends on your doctor’s treatment plan.\n\nBuying Guide for Olmesartan Cilnidipine Chlorthalidone\n\nWhen purchasing Olmesartan, Cilnidipine, and Chlorthalidone, choose:\n\nReputed pharmaceutical brands\nProperly sealed packaging\nCorrect dosage strength\nValid manufacturing and expiry dates\nLicensed pharmacy or trusted supplier\n\nAlways purchase prescription medicines from genuine sources.\n\nFinal Thoughts\n\nOlmesartan, Cilnidipine, and Chlorthalidone is an advanced triple-combination medicine designed for effective blood pressure control when stronger therapy is needed. With the combined benefits of vessel relaxation, improved circulation, and fluid reduction, it offers complete support for patients managing hypertension.",
"price": 109.0,
"discountamount": 33.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"feet",
"risk",
"Email",
"usage",
"adults",
"ankles",
"doctor",
"stroke",
"workload",
"patients",
"headache",
"WhatsApp",
"benefits",
"dizziness",
"blood flow",
"information",
"Cilnidipine",
"sterispharma",
"hypertension",
"sterisonline",
"OLMISTRUM LN",
"heart attack",
"balanced diet",
"blood vessels",
"two components",
"regular exercise",
"healthy lifestyle",
"healthcare provider",
"high blood pressure",
"Common side effects",
"Olmesartan Medoxomil",
"combination medication",
"potential side effects",
"calcium channel blocker",
"other cardiovascular problems",
"angiotensin II receptor antagonist"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1335,
"imageuri": "https://productimages.withfloats.com/actual/69f1c015642f9cb9a8755464.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69f1c015642f9cb9a8755464.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-05T06:19:15.61Z",
"updatedon": "2026-04-29T08:23:48.667Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/olmesartan-cilnidipine-chlorthalidone-olmistrum-trio-20/1335",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "OLMISTRUM TRIO 20",
"category": "CARDIOLOGYRANGE",
"tags": [
"olmesartan cilnidipine chlorthalidone tablet uses",
"olmesartan cilnidipine chlorthalidone tablets benefits",
"olmesartan cilnidipine chlorthalidone side effect",
"olmesartan cilnidipine chlorthalidone buy online",
"buy olmesartan cilnidipine chlorthalidone online",
"olmesartan cilnidipine chlorthalidone lowest price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6a460bf90c11f3c74a816c87",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "methylprednisolone sodium succinate for injection usp",
"description": "Methylprednisolone Sodium Succinate for Injection USP is a fast-acting corticosteroid administered intravenously or intramuscularly to control severe inflammation, allergic reactions, and autoimmune flare-ups. It works by rapidly suppressing the immune and inflammatory response and is used in hospital or clinical settings for acute conditions such as severe asthma attacks, anaphylaxis, autoimmune disease flares, and spinal cord injury protocols. It is a Schedule H prescription drug administered only under medical supervision.\n\nWhat Is Methylprednisolone Sodium Succinate for Injection USP?\n\nMethylprednisolone Sodium Succinate for Injection USP is a water-soluble, injectable corticosteroid used for rapid control of severe inflammatory, allergic, and autoimmune conditions. It is manufactured to United States Pharmacopeia (USP) standards and is typically administered by a healthcare professional via intravenous (IV) or intramuscular (IM) route when fast, high-potency anti-inflammatory or immunosuppressive action is required — situations where oral steroids act too slowly or oral intake isn't feasible.\n\nHow It Works\n\nMethylprednisolone sodium succinate is a synthetic glucocorticoid that acts rapidly once reconstituted and injected.\n\n\nBinds glucocorticoid receptors – enters cells and binds intracellular receptors that regulate inflammatory gene expression.\nSuppresses inflammatory mediators – reduces production of prostaglandins, leukotrienes, and cytokines responsible for swelling, redness, and pain.\nStabilizes cell membranes – reduces capillary permeability, limiting fluid leakage and tissue swelling at the site of inflammation.\nDampens immune overactivity – suppresses lymphocyte and macrophage activity, calming autoimmune or allergic overreactions.\nDelivers rapid systemic action – because it's water-soluble and given IV/IM, onset of anti-inflammatory effect is significantly faster than oral steroids.\n\n\nClinical Indications\n\nConditionWhy Methylprednisolone Injection Is UsedSevere Allergic Reactions / AnaphylaxisRapidly controls swelling, airway inflammation, and allergic cascadeAcute Asthma Exacerbation / COPD FlareReduces airway inflammation when inhalers alone are insufficientAutoimmune Disease Flares (Lupus, Rheumatoid Arthritis)High-dose pulse therapy to control acute flaresSpinal Cord Injury (acute, under specialist protocol)Used in specific clinical protocols to limit secondary inflammationSevere Dermatologic ReactionsControls widespread inflammatory skin reactionsPost-Transplant / Organ Rejection ManagementUsed as part of immunosuppressive regimens\n\nDosage & Administration\n\nParameterRecommendationTypical Adult Dose10–40 mg IV, may range up to 30 mg/kg in high-dose pulse therapy for specific conditionsRouteIntravenous (IV) injection/infusion or Intramuscular (IM) injectionFrequencyAs directed by the treating physician; often single dose or short tapering courseReconstitutionMust be reconstituted only with the accompanying diluent as per product insert, immediately before useAdministration SettingHospital, clinic, or under direct medical/nursing supervision onlyDurationShort-term acute use unless otherwise directed; long-term use requires specialist monitoring\n\nThis is a Schedule H prescription-only medicine. Dosage must be determined and administered by a qualified healthcare professional.\n\nPrecautions\n\n\nTo be administered only by or under the supervision of a healthcare professional.\nNot for self-administration or home use.\nInform the doctor of any active infections, as corticosteroids can mask symptoms and suppress immune response.\nUse with caution in patients with diabetes, hypertension, peptic ulcer disease, osteoporosis, or psychiatric history.\nAvoid live vaccines during treatment due to immunosuppressive effects.\nPregnant or breastfeeding patients should use only under strict medical guidance.\nAbrupt discontinuation after prolonged use should be avoided; tapering may be required as advised by the physician.\n\n\nPossible Side Effects\n\nMost side effects relate to the drug's systemic corticosteroid action and are monitored by the administering clinician:\n\n\nElevated blood sugar levels\nFluid retention, increased blood pressure\nMood changes, insomnia, or restlessness\nNausea or gastrointestinal discomfort\nIncreased susceptibility to infection\nInjection site reactions\n\n\nSerious side effects requiring immediate medical attention include severe allergic reaction, signs of infection (fever, chills), significant mood or behavioral changes, unusual swelling, or vision disturbances. Because this is administered in a clinical setting, the healthcare team monitors for these actively.\n\nComparison: Methylprednisolone vs. Other Injectable Corticosteroids\n\nDrugRelative PotencyCommon Use CaseRouteMethylprednisolone Sodium SuccinateHighAcute severe inflammation, autoimmune flaresIV/IMHydrocortisone Sodium SuccinateLowerAdrenal insufficiency, milder acute inflammationIV/IMDexamethasone Sodium PhosphateVery HighCerebral edema, severe allergic/inflammatory conditionsIV/IMBetamethasone Sodium PhosphateHighAllergic and inflammatory conditions, fetal lung maturityIV/IMTriamcinolone AcetonideModerate (depot)Localized/intra-articular inflammationIM/Intra-articular\n\nKey Statistics\n\nStatisticData PointSourceOnset of anti-inflammatory action after IV administrationWithin 1–2 hours for measurable effectClinical pharmacology references, USP monographUse in acute severe asthma protocolsRecommended as part of systemic corticosteroid therapy in emergency guidelinesGlobal Initiative for Asthma (GINA) guidelinesHospital use in anaphylaxis managementIncluded as an adjunct in anaphylaxis treatment protocols alongside epinephrineWorld Allergy Organization guidanceHigh-dose pulse therapy applicationUsed in select autoimmune flare protocols under specialist supervisionPublished rheumatology treatment guidelines\n\nExpert Insight\n\n[Insert verified physician or clinical pharmacologist commentary here — Claude has not fabricated a quote. Recommend sourcing a short, attributable statement from a Steris Healthcare medical advisor or a cited clinical guideline before publishing.]\n\nConclusion\n\nMethylprednisolone Sodium Succinate for Injection USP is a high-potency, fast-acting corticosteroid reserved for situations where rapid control of severe inflammation, allergic reaction, or autoimmune flare is essential. Administered only under clinical supervision, it plays a critical role in emergency and hospital-based treatment protocols — from anaphylaxis and acute asthma to autoimmune disease management. As a Schedule H medicine, it must never be self-administered; dosage, route, and duration should always be determined by a qualified physician based on the patient's condition. For pharmacopoeia-grade quality and reliable hospital supply, source this injection through a WHO-GMP certified manufacturer.\n\nPrescription only – consult your doctor.\n\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n\n1. What is methylprednisolone sodium succinate injection used for?\nIt is used to rapidly control severe inflammation, allergic reactions, and autoimmune flare-ups, such as anaphylaxis, acute asthma attacks, and lupus or rheumatoid arthritis flares. It is administered under medical supervision in hospital or clinical settings.\n\n2. Is methylprednisolone injection a steroid?\nYes, it is a synthetic corticosteroid (glucocorticoid) that works by suppressing inflammatory and immune responses in the body, providing rapid relief in acute, severe conditions.\n\n3. How is methylprednisolone sodium succinate injection given?\nIt is given by a healthcare professional via intravenous (IV) or intramuscular (IM) injection, after being reconstituted with the correct diluent immediately before administration. It is not for self-injection or home use.\n\n4. How fast does methylprednisolone injection start working?\nBecause it is water-soluble and given directly into the bloodstream or muscle, measurable anti-inflammatory effects typically begin within one to two hours of administration.\n\n5. What are the side effects of methylprednisolone injection?\nCommon effects include elevated blood sugar, fluid retention, mood changes, and increased infection risk. These are monitored by the administering healthcare team, and serious reactions are managed promptly in a clinical setting.\n\n6. Is methylprednisolone sodium succinate injection available without a prescription?\nNo. It is a Schedule H prescription-only medicine that must be administered by or under the direct supervision of a qualified healthcare professional.\n\n7. What is the difference between methylprednisolone and dexamethasone injection?\nBoth are injectable corticosteroids, but dexamethasone has a longer duration of action and higher relative potency, while methylprednisolone is often preferred for acute pulse therapy and shorter-acting systemic control. The choice depends on the clinical scenario and physician judgment.\n\n8. Can methylprednisolone injection be used in pregnancy?\nIt may be used in pregnancy only when clearly necessary and under strict medical supervision, as the treating physician will weigh the benefits against potential risks for the specific condition being treated.",
"price": 47.0,
"discountamount": 19.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2465,
"imageuri": "https://productimages.withfloats.com/actual/6a460bfb9f5529389b8b15b8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a460bfb9f5529389b8b15b8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-02T06:58:01.631Z",
"updatedon": "2026-07-02T06:58:01.631Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//methylprednisolone-sodium-succinate-for-injection-usp/2465",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METHIDENOSOLE 40 INJ",
"category": "GENERAL RANGE",
"tags": [
"methylprednisolone sodium succinate injection uses",
"methylprednisolone sodium succinate injection uses in hindi",
"methylprednisolone sodium succinate",
"methylprednisolone sodium succinate injection",
"inj methylprednisolone sodium succinate",
"methylprednisolone sodium succinate uses in hindi",
"methylprednisolone sodium succinate for injection",
"methylprednisolone sodium succinate injection usp"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69f1f2ab0401258bafb82cd7",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets",
"description": "Managing type 2 diabetes effectively often requires a combination of medicines that work together to control blood sugar levels. DAPAVILDA MET 10/100/500 is a powerful triple-combination tablet formulated with Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 500 mg Tablets. This advanced formulation is designed to help adults with type 2 diabetes maintain better glucose control, improve insulin response, and support overall metabolic health.\n\nIf you are looking for a trusted diabetes management tablet, DAPAVILDA MET 10/100/500 offers a convenient once-daily option under medical supervision.\n\nWhat is DAPAVILDA MET 10/100/500?\n\nDAPAVILDA MET 10/100/500 is a combination medicine used to treat Type 2 Diabetes Mellitus when diet, exercise, or single-drug therapy is not enough to control blood sugar. It contains three clinically proven ingredients:\n\nDapagliflozin 10 mg – Helps remove excess sugar through urine.\nVildagliptin SR 100 mg – Enhances insulin secretion and reduces glucagon release.\nMetformin SR 500 mg – Reduces glucose production in the liver and improves insulin sensitivity.\n\nThis triple-action therapy helps patients achieve better glycemic control and reduces diabetes-related complications.\n\nHow DAPAVILDA MET 10/100/500 Works\n1. Dapagliflozin 10 mg\n\nDapagliflozin belongs to the SGLT2 inhibitor class. It works by blocking glucose reabsorption in the kidneys, allowing excess sugar to pass out through urine. This helps lower blood sugar naturally.\n\n2. Vildagliptin SR 100 mg\n\nVildagliptin is a DPP-4 inhibitor that increases incretin hormone levels. These hormones stimulate insulin release after meals and reduce unnecessary glucose production.\n\n3. Metformin SR 500 mg\n\nMetformin is one of the most trusted diabetes medicines. It decreases glucose production in the liver and improves the body's response to insulin.\n\nTogether, these ingredients provide comprehensive blood sugar management throughout the day.\n\nUses of DAPAVILDA MET 10/100/500\n\nDAPAVILDA MET 10/100/500 Tablets are primarily used for:\n\n✔ Type 2 Diabetes Mellitus\n\nHelps manage high blood sugar levels in adults with type 2 diabetes.\n\n✔ Poorly Controlled Diabetes\n\nUseful when blood sugar remains high despite lifestyle changes or single/dual therapy.\n\n✔ Reduction of HbA1c Levels\n\nSupports long-term sugar control and helps reduce HbA1c.\n\n✔ Weight Management Support\n\nDapagliflozin may assist in mild weight reduction in some diabetic patients.\n\n✔ Improved Metabolic Health\n\nHelps improve insulin sensitivity and glucose utilization.\n\nKey Benefits of DAPAVILDA MET 10/100/500\n1. Triple Combination Formula\n\nThree effective medicines in one tablet for better sugar control.\n\n2. Better Fasting and Post-Meal Sugar Control\n\nHelps control both fasting blood sugar and postprandial spikes.\n\n3. Convenient Once Daily Dosage\n\nSustained release formula supports long-lasting action.\n\n4. Supports Weight Balance\n\nMay help reduce calorie overload through urinary glucose excretion.\n\n5. Helps Lower Risk of Diabetes Complications\n\nGood sugar control may reduce risk of kidney, nerve, eye, and heart problems.\n\n6. Improves Insulin Function\n\nSupports natural insulin release when needed.\n\nWho Can Use DAPAVILDA MET 10/100/500?\n\nThis medicine may be prescribed for:\n\nAdults with type 2 diabetes\nPatients needing triple-drug therapy\nOverweight diabetic individuals\nPatients with uncontrolled HbA1c\nIndividuals requiring convenient once-daily medication\n\nAlways use only after doctor consultation.\n\nRecommended Dosage\n\nThe dosage of DAPAVILDA MET 10/100/500 should be decided by a physician depending on:\n\nBlood sugar levels\nHbA1c results\nKidney function\nExisting medications\nOverall health condition\nGeneral Advice:\nTake with food to reduce stomach upset.\nSwallow whole with water.\nDo not crush or chew SR tablet.\nTake at the same time daily.\nSide Effects of DAPAVILDA MET 10/100/500\n\nLike all medicines, some users may experience mild side effects.\n\nCommon Side Effects\nNausea\nStomach discomfort\nFrequent urination\nHeadache\nLoose stools\nDizziness\nLow appetite\nLess Common Side Effects\nUrinary tract infection\nGenital fungal infection\nDehydration\nWeakness\nSerious Side Effects (Need Immediate Medical Help)\nSevere low sugar (if used with insulin/sulfonylureas)\nLactic acidosis (rare)\nAllergic reaction\nSevere dehydration\nKidney problems\n\nIf unusual symptoms appear, contact a doctor immediately.\n\nPrecautions and Warnings\n\nBefore using DAPAVILDA MET 10/100/500, inform your doctor if you have:\n\nKidney disease\nLiver disease\nHeart problems\nFrequent urinary infections\nHistory of pancreatitis\nAlcohol dependency\nPregnancy or breastfeeding\nImportant:\n\nStay hydrated while taking dapagliflozin-containing medicines.\n\nLifestyle Tips for Better Results\n\nMedicine works best with healthy habits:\n\n✔ Follow a Diabetic Diet\n\nReduce sugar, refined carbs, and oily foods.\n\n✔ Exercise Daily\n\nAt least 30 minutes walking or physical activity.\n\n✔ Monitor Blood Sugar\n\nCheck regularly as advised.\n\n✔ Stay Hydrated\n\nEspecially important with dapagliflozin.\n\n✔ Take Medicine Regularly\n\nDo not skip doses.\n\nWhy Choose DAPAVILDA MET 10/100/500?\n\nPatients and doctors prefer DAPAVILDA MET 10/100/500 because:\n\nTrusted triple therapy\nEffective glucose lowering\nSustained release convenience\nBetter compliance with one tablet\nSuitable for long-term diabetes management under supervision\nStorage Instructions\nStore in a cool, dry place\nKeep away from sunlight\nKeep out of reach of children\nStore below recommended temperature\nConclusion\n\nDAPAVILDA MET 10/100/500 containing Dapagliflozin 10 mg, Vildagliptin SR 100 mg and Metformin SR 500 mg Tablets is a highly effective triple-combination treatment for adults with type 2 diabetes. It helps lower blood sugar, improve insulin response, support weight control, and reduce long-term diabetes risks.",
"price": 325.0,
"discountamount": 98.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2393,
"imageuri": "https://productimages.withfloats.com/actual/69f1f2adf974f5424d3a55fa.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69f1f2adf974f5424d3a55fa.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-04-29T11:59:39.204Z",
"updatedon": "2026-04-29T11:59:39.204Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-mg-vildagliptin-sr-100-mg-and-metformin-sr-500-mg-tablets/2393",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "DAPAVILDA MET 10/100/500",
"category": "DIABETIC RANGE",
"tags": [
"Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69bd056b4b50865defcef3f2",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "olmesartan amlodipine hctz",
"description": "Hypertension (high blood pressure) is one of the most widespread chronic health conditions today, often referred to as a “silent killer” because it can progress without noticeable symptoms. If left unmanaged, it significantly increases the risk of heart attack, stroke, kidney failure, and other life-threatening complications. For patients with moderate to severe or resistant hypertension, single-drug therapy may not be sufficient to achieve optimal control.\n\nTRIOLMISTRUM 40 is an advanced triple-combination medication containing Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide (HCTZ). This powerful formulation is designed to provide comprehensive blood pressure management through three complementary mechanisms, ensuring better control, improved patient outcomes, and long-term cardiovascular protection.\n\nComposition\n\nOlmesartan Medoxomil (40 mg)\n\nAmlodipine (5 mg or as prescribed)\n\nHydrochlorothiazide (12.5 mg or as prescribed)\n\nThis triple combination targets different pathways involved in blood pressure regulation, making it highly effective for patients who require intensive treatment.\n\nHow TRIOLMISTRUM 40 Works\n1. Olmesartan Medoxomil Mechanism\n\nOlmesartan is an Angiotensin II Receptor Blocker (ARB) that:\n\nBlocks the action of angiotensin II, a hormone that narrows blood vessels\n\nRelaxes and widens arteries\n\nReduces blood pressure and improves blood flow\n\nProtects organs such as the heart and kidneys\n\n2. Amlodipine Mechanism\n\nAmlodipine is a calcium channel blocker that:\n\nPrevents calcium from entering the muscle cells of blood vessels\n\nCauses vasodilation (widening of blood vessels)\n\nImproves circulation and reduces resistance in arteries\n\n3. Hydrochlorothiazide (HCTZ) Mechanism\n\nHydrochlorothiazide is a thiazide diuretic that:\n\nHelps eliminate excess salt and water from the body through urine\n\nReduces blood volume\n\nLowers blood pressure and decreases swelling\n\nCombined Effect\n\nThe three drugs work together to:\n\nProvide superior blood pressure control\n\nReduce fluid overload\n\nImprove vascular relaxation\n\nMinimize the risk of cardiovascular complications\n\nUses of TRIOLMISTRUM 40\n1. Treatment of Hypertension\n\nEffective for moderate to severe high blood pressure\n\nSuitable for patients requiring triple therapy\n\n2. Resistant Hypertension\n\nIdeal for individuals whose BP remains uncontrolled with two medications\n\n3. Prevention of Cardiovascular Events\n\nReduces the risk of heart attack, stroke, and heart failure\n\n4. Fluid Retention Management\n\nHelps reduce edema associated with hypertension\n\nKey Benefits of TRIOLMISTRUM 40\n1. Triple Action Formula\n\nCombines three different classes of antihypertensive drugs for maximum effectiveness.\n\n2. Superior Blood Pressure Control\n\nProvides consistent, 24-hour BP reduction\n\nReduces morning BP surges\n\n3. Reduced Risk of Complications\n\nProtects against heart disease and stroke\n\nHelps maintain kidney health\n\n4. Improved Patient Compliance\n\nSingle-tablet therapy reduces pill burden\n\nEasy once-daily dosing\n\n5. Effective in Resistant Cases\n\nWorks well when dual therapy fails\n\n6. Controls Fluid Balance\n\nHCTZ reduces excess fluid and swelling\n\n7. Enhances Overall Cardiovascular Health\n\nImproves blood vessel function\n\nReduces strain on the heart\n\nDosage and Administration\n\nTake TRIOLMISTRUM 40 exactly as prescribed by your doctor\n\nUsually taken once daily, preferably at the same time each day\n\nCan be taken with or without food\n\nAvoid missing doses for consistent BP control\n\nSide Effects of TRIOLMISTRUM 40\n\nLike all medications, TRIOLMISTRUM 40 may cause some side effects.\n\nCommon Side Effects\n\nDizziness\n\nHeadache\n\nFatigue\n\nSwelling of ankles (due to Amlodipine)\n\nIncreased urination\n\nLess Common Side Effects\n\nLow blood pressure (hypotension)\n\nElectrolyte imbalance (low potassium or sodium)\n\nNausea\n\nMuscle cramps\n\nSerious Side Effects (Rare)\n\nSevere dehydration\n\nKidney function changes\n\nIrregular heartbeat\n\nAllergic reactions (rash, itching, swelling)\n\nSeek immediate medical help if serious side effects occur.\n\nPrecautions and Warnings\n\nPregnancy: Not recommended as it may harm the fetus\n\nBreastfeeding: Consult a doctor before use\n\nKidney or Liver Disease: Use with caution\n\nElectrolyte Monitoring: Regular blood tests may be required\n\nAlcohol Consumption: May increase dizziness and risk of low BP\n\nDrug Interactions: Inform your doctor about all medications being taken\n\nWho Should Use TRIOLMISTRUM 40?\n\nThis medication is suitable for:\n\nPatients with uncontrolled or severe hypertension\n\nIndividuals needing triple-drug therapy\n\nPatients at high cardiovascular risk\n\nThose experiencing fluid retention with high BP\n\nLifestyle Tips for Better Results\n\nTo maximize the benefits of TRIOLMISTRUM 40:\n\nFollow a low-salt diet\n\nExercise regularly (at least 30 minutes daily)\n\nMaintain a healthy weight\n\nAvoid smoking and excessive alcohol\n\nPractice stress management techniques\n\nMonitor blood pressure regularly\n\nConclusion\n\nTRIOLMISTRUM 40 (Olmesartan, Amlodipine & Hydrochlorothiazide Tablets) represents a comprehensive and highly effective solution for managing hypertension, especially in patients requiring advanced therapy. Its triple-action formula addresses multiple pathways involved in blood pressure regulation, ensuring better control and long-term protection against cardiovascular complications.",
"price": 135.0,
"discountamount": 95.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2345,
"imageuri": "https://productimages.withfloats.com/actual/69bd056e8a311bc9dd97e3e7.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69bd056e8a311bc9dd97e3e7.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-03-20T08:29:31.42Z",
"updatedon": "2026-03-20T08:29:31.42Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//olmesartan-amlodipine-hctz/2345",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TRIOLMISTRUM 40",
"category": "CARDIOLOGYRANGE",
"tags": [
"olmesartan amlodipine hctz",
"olmesartan amlodipine hydrochlorothiazide combination benefits",
"olmesartan amlodipine hctz dosage guide",
"olmesartan amlodipine hctz tablets for hypertension",
"olmesartan amlodipine hctz how it works",
"best time to take olmesartan amlodipine hctz tablets",
"olmesartan amlodipine hctz tablets review india",
"olmesartan amlodipine hctz tablets for uncontrolled bp",
"best medicine for high bp triple combination india",
"olmesartan amlodipine hctz tablets for stage 2 hypertension",
"triple therapy tablets for high blood pressure india",
"what is olmesartan amlodipine hctz used for",
"olmesartan amlodipine hctz morning or night",
"olmesartan amlodipine hctz side effects in hindi",
"buy olmesartan amlodipine hctz tablets online",
"olmesartan amlodipine hctz tablets price in india",
"lmesartan amlodipine hctz bulk supplier india",
"best olmesartan amlodipine hctz brand in india",
"olmesartan amlodipine hctz vs telmisartan combination"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6912fc8c470ec71b0ac87646",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "mometasone furoate formoterol fumarate inhaler",
"description": "Mometasone Furoate and Formoterol Fumarate Inhaler is a combination respiratory medication formulated to provide effective and long-lasting control of asthma and chronic obstructive pulmonary disease (COPD). It combines two powerful active ingredients — Mometasone Furoate, a corticosteroid (anti-inflammatory), and Formoterol Fumarate, a long-acting bronchodilator (LABA). Together, these components help patients breathe easier by reducing airway inflammation and relaxing the muscles of the airways.\n\nThis dual-action inhaler is designed for maintenance therapy rather than immediate relief of acute symptoms. By targeting both inflammation and bronchial constriction, it provides a comprehensive approach to long-term respiratory management. Each inhalation delivers a precise dose to ensure consistent therapeutic results and improved lung function.\n\nMometasone Furoate and Formoterol Fumarate Inhaler is ideal for individuals who experience persistent asthma symptoms or airflow obstruction due to COPD, despite using single-ingredient inhalers.\n\nUses and Therapeutic Indications\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler is prescribed for the following respiratory conditions:\n\nAsthma (Bronchial Asthma):\n\nUsed for the long-term control and prevention of symptoms such as wheezing, breathlessness, and chest tightness.\n\nHelps reduce inflammation and airway hyperreactivity to prevent asthma attacks.\n\nChronic Obstructive Pulmonary Disease (COPD):\n\nHelps manage chronic bronchitis and emphysema by improving airflow and reducing airway inflammation.\n\nMaintenance Therapy:\n\nProvides ongoing treatment for patients whose symptoms are not adequately controlled by inhaled corticosteroids or bronchodilators alone.\n\nThis inhaler is not meant for emergency relief during sudden asthma attacks but rather as a daily maintenance therapy to control symptoms and prevent exacerbations.\n\nKey Benefits\n\nDual Mechanism of Action:\nCombines the anti-inflammatory power of Mometasone Furoate with the bronchodilating action of Formoterol Fumarate, offering complete respiratory control in one inhaler.\n\nReduces Airway Inflammation:\nMometasone Furoate suppresses the body’s inflammatory response, helping reduce swelling, mucus buildup, and irritation in the airways.\n\nLong-Lasting Bronchodilation:\nFormoterol provides fast and sustained relaxation of airway muscles, improving airflow and making breathing easier for up to 12 hours.\n\nImproves Lung Function:\nRegular use enhances pulmonary capacity, allowing patients to perform daily activities without breathing difficulty.\n\nFewer Asthma Exacerbations:\nReduces the frequency and severity of asthma attacks and flare-ups associated with COPD.\n\nConvenient Combination Therapy:\nProvides the benefits of two medications in a single device, improving compliance and simplifying treatment routines.\n\nBetter Symptom Control:\nProven to decrease wheezing, coughing, and nighttime symptoms, leading to better sleep and overall quality of life.\n\nRapid Onset of Action:\nFormoterol acts within minutes to ease breathing while Mometasone works continuously to maintain long-term inflammation control.\n\nPossible Side Effects\n\nWhile the Mometasone Furoate and Formoterol Fumarate Inhaler is well tolerated, some individuals may experience mild to moderate side effects, especially during the early phase of therapy. These include:\n\nThroat Irritation or Dryness\n\nHoarseness or Voice Changes\n\nHeadache or Dizziness\n\nCough or Upper Respiratory Tract Infections\n\nMuscle Cramps or Tremors\n\nPalpitations (Fast or Irregular Heartbeat)\n\nNausea or Mild Stomach Upset\n\nOral Thrush (Fungal Infection in the Mouth or Throat) – often preventable by rinsing the mouth with water after inhalation.\n\nPrecautions:\n\nThis inhaler is not a rescue medication; a short-acting bronchodilator should be kept on hand for sudden breathing attacks.\n\nRegular use is essential for best results — do not stop suddenly without consulting a doctor.\n\nPatients with heart conditions, hypertension, thyroid disorders, diabetes, or osteoporosis should use this medicine under medical supervision.\n\nAlways rinse the mouth after use to prevent fungal infections.\n\nConclusion\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler represents a modern, evidence-based approach to managing chronic respiratory conditions such as asthma and COPD. By combining a corticosteroid (to reduce airway inflammation) with a long-acting bronchodilator (to open the airways), it provides effective, dual-action relief that lasts throughout the day.\n\nRegular use of this inhaler helps improve breathing capacity, reduces symptom frequency, and enhances quality of life for individuals struggling with chronic lung diseases. It not only helps patients achieve better control over their respiratory symptoms but also reduces the need for emergency interventions and hospitalizations.",
"price": 360.0,
"discountamount": 108.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2199,
"imageuri": "https://productimages.withfloats.com/actual/6912fc8e6447ec42b9808956.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6912fc8e6447ec42b9808956.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-11T09:06:20.511Z",
"updatedon": "2026-03-14T08:49:38.354Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mometasone-furoate-formoterol-fumarate-inhaler/2199",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MONTASENSE F INH",
"category": "ASTHMA RANGE",
"tags": [
"Mometasone Furoate and Formoterol Fumarate Inhaler",
"respiratory medication",
"chronic obstructive pulmonary disease (COPD)",
"muscles of the airways.",
"respiratory control in one inhaler",
"Mometasone Furoate Formoterol Fumarate inhaler for asthma treatment",
"Mometasone Furoate Formoterol Fumarate dosage guide",
"Mometasone Furoate Formoterol Fumarate inhaler side effects",
"Best time to use Mometasone Furoate Formoterol Fumarate inhaler",
"Buy Mometasone Furoate Formoterol Fumarate inhaler online",
"Mometasone Furoate Formoterol Fumarate inhaler price per unit",
"Where to purchase Mometasone Furoate Formoterol Fumarate inhaler",
"Mometasone Furoate Formoterol Fumarate inhaler buy at the best price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66600480161afa2274ff3048",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "olmesartan cilnidipine chlorthalidone",
"description": "OLMISTRUM TRIO\nManaging high blood pressure often requires a combination approach, especially when a single medication does not provide adequate control. The combination of Olmesartan, Cilnidipine, and Chlorthalidone is a powerful triple-therapy formulation designed to effectively regulate blood pressure and reduce the risk of cardiovascular complications. This advanced combination is widely prescribed by healthcare professionals for patients with moderate to severe hypertension who need multi-mechanism treatment.\n\nIf you are exploring this medicine for purchase or prescription purposes, this detailed guide will help you understand how it works, its benefits, usage, and important considerations.\n\nWhat is Olmesartan Cilnidipine Chlorthalidone?\n\nOlmesartan Cilnidipine Chlorthalidone is a fixed-dose combination medicine used to treat hypertension (high blood pressure). It contains three active ingredients:\n\nOlmesartan Medoxomil – an angiotensin II receptor blocker (ARB)\nCilnidipine – a calcium channel blocker (CCB)\nChlorthalidone – a thiazide-like diuretic\n\nTogether, these components provide a comprehensive approach to lowering blood pressure by targeting different pathways in the body.\n\nHow Does Olmesartan Cilnidipine Chlorthalidone Work?\n\nEach component plays a unique role:\n\n1. Olmesartan Medoxomil\n\nOlmesartan blocks the action of angiotensin II, a substance that causes blood vessels to tighten. By preventing this effect, it helps relax blood vessels, improving blood flow and lowering blood pressure.\n\n2. Cilnidipine\n\nCilnidipine works by blocking calcium channels in blood vessel walls, leading to vasodilation (widening of blood vessels). It also reduces sympathetic nerve activity, which helps control heart rate and pressure more effectively.\n\n3. Chlorthalidone\n\nChlorthalidone is a diuretic that removes excess salt and water from the body through urine. This reduces blood volume and, consequently, lowers blood pressure.\n\nCombined Effect:\nThe triple-action mechanism ensures stronger and more sustained blood pressure control compared to single or dual therapy.\n\nUses of Olmesartan Cilnidipine Chlorthalidone\n\nThis combination is primarily prescribed for:\n\nTreatment of moderate to severe hypertension\nPatients not responding adequately to single or dual drug therapy\nPrevention of cardiovascular risks such as:\nHeart attack\nStroke\nKidney damage\n\nIt is often recommended for long-term blood pressure management.\n\nKey Benefits of Olmesartan Cilnidipine Chlorthalidone\n1. Superior Blood Pressure Control\n\nThe combination targets multiple mechanisms, offering more effective control than individual drugs.\n\n2. Reduced Risk of Heart Diseases\n\nBy maintaining stable blood pressure levels, it significantly lowers the risk of heart attack and stroke.\n\n3. Kidney Protection\n\nOlmesartan helps protect kidney function, especially in patients with diabetes or chronic hypertension.\n\n4. Improved Patient Compliance\n\nInstead of taking multiple pills, patients can take a single tablet, improving adherence to treatment.\n\n5. Long-Lasting Effect\n\nChlorthalidone provides prolonged diuretic action, ensuring consistent blood pressure control throughout the day.\n\nDosage and Administration\nThe dosage is determined by a healthcare professional based on the patient’s condition.\nTypically, it is taken once daily, with or without food.\nIt is advisable to take the medicine at the same time every day for best results.\nDo not skip doses or stop the medication abruptly without consulting a doctor.\nWho Should Consider This Combination?\n\nThis medication is suitable for:\n\nPatients with uncontrolled hypertension\nIndividuals requiring triple-drug therapy\nPatients with high cardiovascular risk factors\nThose needing long-term blood pressure stabilization\nPossible Side Effects\n\nLike all medications, Olmesartan Cilnidipine Chlorthalidone may cause some side effects. Most are mild and temporary:\n\nCommon Side Effects\nDizziness or lightheadedness\nFatigue\nHeadache\nSwelling in ankles (due to Cilnidipine)\nIncreased urination\nLess Common Side Effects\nElectrolyte imbalance (low potassium or sodium)\nDehydration\nMuscle cramps\nLow blood pressure (hypotension)\nSerious Side Effects (Rare)\nSevere allergic reactions\nKidney function changes\nIrregular heartbeat\n\nIf any severe symptoms occur, immediate medical attention is required.\n\nPrecautions and Warnings\n\nBefore taking this medicine, consider the following:\n\n1. Pregnancy and Breastfeeding\nNot recommended during pregnancy due to potential risk to the fetus.\nConsult a doctor if breastfeeding.\n2. Kidney or Liver Disorders\nPatients with impaired kidney or liver function should use it cautiously.\n3. Electrolyte Imbalance\nRegular monitoring of potassium and sodium levels is essential.\n4. Alcohol Consumption\nAvoid alcohol as it may enhance dizziness and lower blood pressure excessively.\n5. Driving and Machinery\nMay cause dizziness; avoid activities requiring alertness until you know how the medicine affects you.\nDrug Interactions\n\nOlmesartan Cilnidipine Chlorthalidone may interact with:\n\nOther antihypertensive medications\nNSAIDs (painkillers)\nLithium\nPotassium supplements or potassium-sparing diuretics\n\nAlways inform your doctor about all medicines and supplements you are taking.\n\nStorage Instructions\nStore in a cool, dry place away from direct sunlight.\nKeep out of reach of children.\nDo not use expired medication.\nWhy Choose Olmesartan Cilnidipine Chlorthalidone?\n\nWhen it comes to managing hypertension effectively, this triple combination stands out because of its:\n\nMulti-mechanism action\nLong-lasting effect\nProven clinical efficacy\nConvenience of a single-tablet regimen\n\nFor patients struggling with uncontrolled blood pressure, this combination offers a reliable and effective solution.\n\nBuying Considerations\n\nIf you are planning to purchase Olmesartan Cilnidipine Chlorthalidone, keep the following in mind:\n\nAlways buy from a trusted pharmaceutical provider\nEnsure the product is approved and properly labeled\nCheck the dosage strength recommended by your doctor\nCompare pricing and availability from reliable suppliers\nConclusion\n\nOlmesartan, cilnidipine, and chlorthalidone is a highly effective triple-combination therapy designed for comprehensive hypertension management. By combining the benefits of an ARB, calcium channel blocker, and diuretic, it provides superior blood pressure control and reduces the risk of serious cardiovascular complications.",
"price": 145.0,
"discountamount": 44.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"Call",
"body",
"Email",
"water",
"removal",
"WhatsApp",
"diuretic",
"blood flow",
"Olmesartan",
"information",
"excess salt",
"Cilnidipine",
"sterisonline",
"sterispharma",
"hypertension",
"blood vessels",
"Chlorthalidone",
"OLMISTRUM TRIO",
"urine production",
"high blood pressure",
"combination medication",
"calcium channel blocker",
"angiotensin II receptor antagonist"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1336,
"imageuri": "https://productimages.withfloats.com/actual/66600483c40ee9be01972f95.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66600483c40ee9be01972f95.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-05T06:24:00.801Z",
"updatedon": "2026-04-29T07:20:11.353Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//olmesartan-cilnidipine-chlorthalidone/1336",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "OLMISTRUM TRIO",
"category": "CARDIOLOGYRANGE",
"tags": [
"olmesartan cilnidipine chlorthalidone tablet uses",
"olmesartan cilnidipine chlorthalidone tablets benefits",
"olmesartan cilnidipine chlorthalidone side effect",
"olmesartan cilnidipine chlorthalidone for high blood pressure",
"olmesartan cilnidipine chlorthalidone medicine for hypertension",
"buy olmesartan cilnidipine chlorthalidone online",
"olmesartan cilnidipine chlorthalidone best price India",
"olmesartan cilnidipine chlorthalidone wholesale supplier",
"olmesartan cilnidipine chlorthalidone buy now",
"olmesartan cilnidipine chlorthalidone bulk order India"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a6def248b0777b5cb29791c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Propranolol Hydrochloride Sustained Release Capsules IP",
"description": "PROPASULES LA 40 is a premium pharmaceutical formulation containing Propranolol Hydrochloride Sustained Release Capsules IP 40 mg. Developed with advanced sustained-release technology, this formulation delivers the active ingredient gradually over an extended period, helping maintain consistent therapeutic levels while supporting the convenience of once-daily administration when prescribed by a healthcare professional.\n\nManufactured in GMP-certified facilities using pharmaceutical-grade raw materials, PROPASULES LA 40 is produced under strict quality control measures to ensure purity, safety, and batch-to-batch consistency. It is intended for the treatment of medical conditions in which propranolol therapy is considered appropriate by a qualified physician.\n\nComposition\n\nEach Sustained Release Capsule Contains:\n\nPropranolol Hydrochloride IP – 40 mg\nSustained Release Pellets\nPharmaceutical Excipients – q.s.\nCapsule Shell – Approved pharmaceutical-grade ingredients\n\nDosage Form: Sustained Release Capsules\n\nWhat is PROPASULES LA 40?\n\nPROPASULES LA 40 contains Propranolol Hydrochloride, a non-selective beta-adrenergic receptor blocker (beta-blocker) that helps manage a variety of cardiovascular and neurological conditions. The sustained-release formulation is specifically designed to release the medicine gradually throughout the day, providing prolonged therapeutic action and helping maintain stable plasma drug concentrations compared with conventional immediate-release formulations.\n\nIts controlled-release technology enhances dosing convenience and supports consistent treatment outcomes when used according to medical advice.\n\nKey Features\nContains Propranolol Hydrochloride Sustained Release IP 40 mg\nAdvanced sustained-release technology for prolonged drug delivery\nSupports once-daily dosing as prescribed\nManufactured using premium pharmaceutical-grade ingredients\nProduced in GMP-compliant manufacturing facilities\nStringent quality assurance for consistent product performance\nReliable formulation for long-term therapeutic use under medical supervision\nTherapeutic Uses\n\nHealthcare professionals may prescribe PROPASULES LA 40 for the management of several cardiovascular and neurological disorders, including:\n\nHypertension (high blood pressure)\nChronic stable angina\nCardiac arrhythmias\nPrevention of migraine attacks\nEssential tremor\nPhysical symptoms associated with anxiety\nCardiovascular manifestations of hyperthyroidism\nSecondary prevention following myocardial infarction, when clinically indicated\n\nThe choice of treatment, dosage, and duration should always be individualized based on the patient's medical condition and physician's assessment.\n\nHow PROPASULES LA 40 Works\n\nPropranolol Hydrochloride works by blocking beta-adrenergic receptors located in the heart and other tissues. This action reduces the effects of adrenaline and other stress hormones on the cardiovascular system.\n\nAs a result, the medicine may help:\n\nSlow the heart rate\nReduce the workload on the heart\nLower elevated blood pressure\nImprove control of certain abnormal heart rhythms\nReduce the frequency of migraine episodes\nMinimize symptoms associated with essential tremor\nRelieve physical manifestations of anxiety, such as rapid heartbeat and trembling\n\nThe sustained-release pellets gradually release the medication throughout the day, providing prolonged therapeutic coverage and reducing fluctuations in drug levels.\n\nBenefits of the Sustained Release Formulation\n\nThe advanced sustained-release technology offers several advantages:\n\nControlled and gradual release of the active ingredient\nExtended therapeutic effect throughout the dosing interval\nMore consistent blood concentrations of the medication\nReduced peak-to-trough fluctuations compared with immediate-release formulations\nConvenient dosing schedule that may improve treatment adherence\nSuitable for long-term therapy under medical supervision\n\nTreatment outcomes depend on individual patient response and adherence to the prescribed regimen.\n\nDosage and Administration\n\nTake PROPASULES LA 40 exactly as instructed by your healthcare provider.\n\nGeneral recommendations include:\n\nSwallow the capsule whole with sufficient water.\nDo not crush, chew, or open the capsule unless specifically advised.\nTake the medicine at the same time every day.\nFollow the prescribed dosage schedule carefully.\nDo not discontinue treatment abruptly without consulting your physician, as sudden withdrawal may increase the risk of cardiovascular complications.\nPossible Side Effects\n\nLike all medications, PROPASULES LA 40 may cause side effects in some individuals, although many patients tolerate it well.\n\nCommon side effects may include:\n\nFatigue\nDizziness\nSlow heartbeat\nCold hands and feet\nNausea\nSleep disturbances\nMild stomach discomfort\n\nSeek immediate medical attention if you experience breathing difficulty, severe dizziness, fainting, swelling of the face or throat, or signs of a serious allergic reaction.\n\nConsult your healthcare provider if any side effects persist or become troublesome.\n\nPrecautions and Warnings\n\nBefore starting PROPASULES LA 40, inform your doctor if you have:\n\nAsthma or chronic obstructive pulmonary disease (COPD)\nDiabetes mellitus\nLiver impairment\nKidney disease\nHeart failure\nLow blood pressure\nBradycardia (slow heart rate)\nPeripheral vascular disease\nThyroid disorders\nHistory of hypersensitivity reactions\n\nYour physician should also be informed about all prescription medicines, over-the-counter drugs, herbal supplements, and dietary products you are taking to minimize the risk of drug interactions.\n\nPregnancy and Breastfeeding\n\nThe use of PROPASULES LA 40 during pregnancy or breastfeeding should only be considered when recommended by a qualified healthcare professional after carefully evaluating the potential benefits and possible risks.\n\nAlways consult your physician before taking this medicine during pregnancy or while nursing.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from moisture and direct sunlight.\nKeep below the storage temperature specified on the product label.\nStore in the original packaging until use.\nKeep out of the reach of children.\nDo not use the medicine after the expiry date printed on the pack.\nWhy Choose PROPASULES LA 40?\n\nPROPASULES LA 40 is formulated to deliver dependable therapeutic performance through advanced sustained-release technology. Manufactured under stringent pharmaceutical quality standards, it combines consistent drug delivery, convenient dosing, and reliable product quality to support long-term cardiovascular and neurological care.\n\nKey Advantages\n\nPremium sustained-release Propranolol formulation\nControlled drug release for prolonged therapeutic action\nConvenient once-daily administration as prescribed\nManufactured in GMP-certified facilities\nHigh standards of quality, purity, and consistency\nReliable formulation for chronic disease management\nFrequently Asked Questions (FAQs)\nWhat is PROPASULES LA 40 prescribed for?\n\nPROPASULES LA 40 may be prescribed for conditions such as hypertension, chronic angina, cardiac arrhythmias, migraine prevention, essential tremor, anxiety-related physical symptoms, and certain cardiovascular conditions, depending on the physician's evaluation.\n\nCan PROPASULES LA 40 be taken once a day?\n\nYes. The sustained-release formulation is designed to support convenient once-daily dosing when prescribed by a healthcare professional.\n\nCan I stop taking PROPASULES LA 40 suddenly?\n\nNo. Abrupt discontinuation of propranolol may increase the risk of serious cardiovascular events. Always consult your doctor before stopping treatment.\n\nCan people with diabetes take PROPASULES LA 40?\n\nPatients with diabetes should use this medicine only under medical supervision, as beta-blockers may mask some warning signs of low blood sugar.\n\nIs PROPASULES LA 40 suitable for every patient?\n\nNo. This medicine may not be appropriate for individuals with certain conditions such as severe asthma, significant bradycardia, or specific cardiac disorders. Your healthcare provider will determine whether it is suitable for your individual medical needs.",
"price": 45.0,
"discountamount": 14.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2490,
"imageuri": "https://productimages.withfloats.com/actual/6a6def271f223d84dee2d962.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a6def271f223d84dee2d962.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-01T13:05:40.676Z",
"updatedon": "2026-08-01T13:05:40.676Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//propranolol-hydrochloride-sustained-release-capsules-ip/2490",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PROPASULES LA 40",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}